You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

myopic choroidal neovascularisation

Showing 1 - 25 of 756
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myopic Choroidal Neovascularisation Trial in Guangzhou (3+PRN, 6+PRN)

Recruiting
  • Myopic Choroidal Neovascularisation
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Feb 8, 2022

Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation, Proliferative Diabetic Retinopathy Trial in Perugia

Not yet recruiting
  • Macular Degeneration, Age Related
  • +4 more
  • VISUPRIME
  • Placebo
  • Perugia, PG, Italy
    Ospedale Santa Maria della Misericordia
Dec 22, 2022

Diabetic Macular Edema, Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Banha (Anti-vascular endothelial

Recruiting
  • Diabetic Macular Edema
  • +4 more
  • Anti-vascular endothelial growth factors (Anti-VEGFs)
  • Banhā, Benha, Egypt
    Ahmed Abdelshafy Tabl
Aug 8, 2022

Real Life Study in Myopic Neovascularization

Active, not recruiting
  • Myopic Choroidal Neovascularisation
  • AFLIBERCEPT
  • Poitiers, France
    Chu de Poitiers
Sep 28, 2021

Central Retinal Vein Occlusion With Macular Edema Trial in Tanta (Ziv-Aflibercept 25 MG/ML [Zaltrap])

Completed
  • Central Retinal Vein Occlusion With Macular Edema
  • Ziv-Aflibercept 25 MG/ML [Zaltrap]
  • Tanta, El Gharbia, Egypt
    Tanta University
Oct 4, 2021

Myopic Choroidal Neovascularisation Trial in Beijing (CM082)

Suspended
  • Myopic Choroidal Neovascularisation
  • Beijing, China
    Peking Union Medical College Hospital
Mar 7, 2021

Pathologic Myopia Trial in Mykolaiv, Odessa (Intravitreal injection)

Completed
  • Pathologic Myopia
  • Intravitreal injection
  • Mykolaiv, Ukraine
  • +2 more
Jan 23, 2023

Learn More About How Drug Aflibercept Works in Canadian Reduced

Active, not recruiting
  • Myopic Choroidal Neovascularization
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Canada
    Many Locations
Jul 25, 2022

Pathological Myopic Choroidal Neovascularization Trial in BeiJing (601, Ranibizumab)

Recruiting
  • Pathological Myopic Choroidal Neovascularization
  • BeiJing, China
    Peking Union Medical College Hospital
Jun 4, 2021

Pathologic Myopia Trial in Lutsk, Mykolaiv, Odesa (Intravitreal injection)

Recruiting
  • Pathologic Myopia
  • Intravitreal injection
  • Lutsk, Ukraine
  • +3 more
Mar 23, 2022

Chorioretinitis Trial in Mykolaiv, Odessa (Intravitreal injection, Fluorescent angiography, Visometry)

Unknown status
  • Chorioretinitis
  • Intravitreal injection
  • +6 more
  • Mykolaiv, Ukraine
  • +2 more
Feb 2, 2021

Induced Defocus to the Retina Trial in Houston (Plus powered optical lens)

Completed
  • Induced Defocus to the Retina
  • Plus powered optical lens
  • Houston, Texas
    University of Houston College of Optometry
Mar 15, 2022

Angioid Streaks of Macula Trial in Mykolaiv, Odessa (Intravitreal injection)

Recruiting
  • Angioid Streaks of Macula
  • Intravitreal injection
  • Mykolaiv, Ukraine
  • +2 more
Feb 2, 2021

Retinal Perforations, Myopia, Degenerative Trial in Hangzhou (corneal flap transplantation)

Active, not recruiting
  • Retinal Perforations
  • Myopia, Degenerative
  • corneal flap transplantation
  • Hangzhou, Zhejiang, China
    Department of Ophthalmology, Affiliated Hangzhou First People's
May 17, 2023

Myopia, Progressive Trial in Shanghai (Airdoc Red Lighting Device, Special Spectacles to Control Myopia)

Recruiting
  • Myopia, Progressive
  • Airdoc Red Lighting Device
  • Special Spectacles to Control Myopia
  • Shanghai, China
    Shanghai Children Medical Center
May 21, 2023

Myopia, Refractive Errors, Eye Diseases Trial in Shanghai (RLRL)

Not yet recruiting
  • Myopia
  • +3 more
  • RLRL
  • Shanghai, Shanghai, China
    Shanghai Eye Disease Prevention and Treatment Center
Oct 24, 2022

Myopia Trial in Shanghai (Shorter-wavelength dominant light, Light similar to the solar spectrum proportion, Longer-wavelength

Recruiting
  • Myopia
  • Shorter-wavelength dominant light
  • +2 more
  • Shanghai, Shanghai, China
  • +1 more
Oct 25, 2022

Emmetropization, Myopia, Hyperopia Trial (DEFOG glasses(peripheral focus-out glasses))

Not yet recruiting
  • Emmetropization
  • +2 more
  • DEFOG glasses(peripheral focus-out glasses)
  • (no location specified)
Jan 10, 2023

AMD, Age-related Macular Degeneration, Choroidal Neovascularisation Trial in Poitiers (Resvega, Trans-Resveratrol, )

Terminated
  • AMD
  • +2 more
  • Resvega
  • +2 more
  • Poitiers, France
    CHU de Poitiers - Ophtalmology
May 29, 2020

Myopia, Severe Trial (Structural and fonctional phynotyping)

Not yet recruiting
  • Myopia, Severe
  • Structural and fonctional phynotyping
  • (no location specified)
Apr 28, 2023

Myopia, Progressive Trial in Xuzhou (PBM, Peripheral defocus spectacles, Single vision spectacles)

Recruiting
  • Myopia, Progressive
  • PBM
  • +2 more
  • Xuzhou, Jiangsu, China
    the first people's hospital of Xuzhou
Mar 7, 2023

Myopia Trial in Shanghai (Weak outdoor light, Strong outdoor light)

Recruiting
  • Myopia
  • Weak outdoor light
  • Strong outdoor light
  • Shanghai, Shanghai, China
    Shanghai Eye Disease Prevention and Treatment Center
Oct 25, 2022

RCT on Red Light Treatment for Myopic Minors' Retinal Impact

Recruiting
  • Red Laser Light-Induced Retinopathy of Both Eyes (Diagnosis)
    • Guangzhou, China
      Sun Yat-sen University Zhongshan Ophthalmic Center (Zhujiang New
    Sep 12, 2023

    Quantitative Metamorphopsia- Measurements in Patients With mCNV

    Completed
    • Metamorphopsia
    • App
    • Binningen, Baselland, Switzerland
      Vista Klinik
    Dec 8, 2021

    Myopia Trial in Vejle (Orthokeratology lenses)

    Completed
    • Myopia
    • Orthokeratology lenses
    • Vejle, Jylland, Denmark
      Vejle Hospital
    Mar 3, 2022